Tick-borne nairoviruses are emerging as a significant public health concern, particularly with the recent identification of Pacific Coast Tick nairovirus (PCTNV) in the western United States. This virus, carried by a human-biting tick, has the potential to evade human immune defenses through the use of specialized enzymes called OTU proteases. These proteases can remove critical protein tags, such as ubiquitin and ISG15, which normally act as alarm signals that activate immune responses. The study, published in ACS Infectious Diseases, reveals that PCTNV's OTU protease is particularly adept at removing these tags, suggesting that it may be unusually effective at evading human immunity. This finding is concerning, given the presence of the tick species that carries PCTNV across the Pacific Coast. The research also provides structural insights into the OTU proteases, allowing for the development of predictive models that can help public health agencies monitor new tick-borne viruses before they spread widely. As the study's corresponding author, Scott D. Pegan, noted, the identification of the type of tick that an individual has been bitten by is crucial in understanding the potential diseases that may be present beyond the typical ones we are accustomed to looking for. This highlights the importance of vigilance and awareness in tick-borne disease prevention and management.
